Azerbaijan Society of Cardiology

2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension

Our guidelines support healthcare professionals with the diagnosis and management of elevated blood pressure and hypertension.

2024 ESC Guidelines for the management of atrial fibrillation

In this iteration of the European Society of Cardiology (ESC) Clinical Practice Guidelines on Atrial Fibrillation, the task force has consolidated and evolved past approaches to develop the AF-CARE framework.

2024 ESC Guidelines for the management of peripheral arterial and aortic diseases

These guidelines provide a comprehensive framework for healthcare professionals, covering the entire PAAD patient journey.

2024 ESC Guidelines for the management of chronic coronary syndromes

The current guidelines for managing chronic coronary syndromes (CCS) are intended to assist in diagnosing and initiating treatment for individuals with suspected CCS, as well as in the longterm management of patients with confirmed CCS.

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes

The current Guidelines on cardiovascular disease and diabetes are designed to guide prevention and management of the manifestations of CVD in patients with diabetes.

2023 ESC Guidelines for the management of endocarditis

2023 ESC Guidelines for the management of cardiomyopathies

The objective of this guideline is to help healthcare professionals diagnose and manage patients with cardiomyopathies of all ages according to the best available evidence and to provide a practical diagnostic and treatment framework for patients and their relatives.

2023 ESC Guidelines for the management of acute coronary syndromes

The present guideline has been developed to support healthcare professionals in the diagnosis and management of patients presenting with acute coronary syndrome (ACS). For the first time, the present guideline presents recommendations for management of patients across the entire spectrum of ACS in one document.

2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

Since the publication of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, there have been several randomised controlled trials that should change patient management ahead of the next scheduled full guideline.

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Pulmonary hypertension (PH) is a pathophysiological disorder, which may involve multiple clinical conditions and may be associated with a variety of cardiovascular and respiratory diseases.

2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice

The present guidelines have been developed to support healthcare professionals in their efforts to reduce the burden of ASCVD in both individual patients, as well as at a population level.

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

The aim of this ESC guideline is to help health professionals manage people with heart failure (HF) according to the best available evidence. Fortunately, we now have a wealth of clinical trials to help us select the best management to improve the outcomes for people with HF; for many, it is now both preventable and treatable.

2019 Guidelines on Acute Pulmonary Embolism (Diagnosis and Management of)

This document follows the previous ESC guidelines focusing on the clinical management of pulmonary embolism (PE) published in 2000, 2008, and 2014.

2019 ESC/EAS Guidelines for the management of dyslipidaemias

These ESC/EAS Guidelines on lipids provide important new advice on patient management, which should enable more clinicians to efficiently and safely reduce CV risk through lipid modification.